Abstract

The inhibitor of κB (IκB) kinase (IKK) is a central regulator of NF-κB signaling. All IKK complexes contain hetero- or homodimers of the catalytic IKKβ and/or IKKα subunits. Here, we identify a YDDΦxΦ motif, which is conserved in substrates of canonical (IκBα, IκBβ) and alternative (p100) NF-κB pathways, and which mediates docking to catalytic IKK dimers. We demonstrate a quantitative correlation between docking affinity and IKK activity related to IκBα phosphorylation/degradation. Furthermore, we show that phosphorylation of the motif’s conserved tyrosine, an event previously reported to promote IκBα accumulation and inhibition of NF-κB gene expression, suppresses the docking interaction. Results from integrated structural analyzes indicate that the motif binds to a groove at the IKK dimer interface. Consistently, suppression of IKK dimerization also abolishes IκBα substrate binding. Finally, we show that an optimized bivalent motif peptide inhibits NF-κB signaling. This work unveils a function for IKKα/β dimerization in substrate motif recognition.

The inhibitor of kB kinase (IKK) is a central regulator of NF-kB signalling. Here the authors identify a motif conserved in substrates of canonical and alternative NF-kB pathways which mediates docking to catalytic IKK dimers: they show that phosphorylation of the conserved tyrosine suppresses the docking interaction.

Details

Title
Molecular mechanism of IKK catalytic dimer docking to NF-κB substrates
Author
Li, Changqing 1 ; Moro, Stefano 1 ; Shostak, Kateryna 2   VIAFID ORCID Logo  ; O’Reilly, Francis J. 3   VIAFID ORCID Logo  ; Donzeau, Mariel 1 ; Graziadei, Andrea 3 ; McEwen, Alastair G. 4   VIAFID ORCID Logo  ; Desplancq, Dominique 1 ; Poussin-Courmontagne, Pierre 4   VIAFID ORCID Logo  ; Bachelart, Thomas 1 ; Fiskin, Mert 1 ; Berrodier, Nicolas 4 ; Pichard, Simon 4   VIAFID ORCID Logo  ; Brillet, Karl 5   VIAFID ORCID Logo  ; Orfanoudakis, Georges 1 ; Poterszman, Arnaud 4   VIAFID ORCID Logo  ; Torbeev, Vladimir 1 ; Rappsilber, Juri 3   VIAFID ORCID Logo  ; Davey, Norman E. 6 ; Chariot, Alain 7 ; Zanier, Katia 1   VIAFID ORCID Logo 

 Boulevard Sébastien Brant, Biotechnology and Cell Signaling (CNRS/Université de Strasbourg, UMR7242), Ecole Superieure de Biotechnologie de Strasbourg, Illkirch, France (GRID:grid.418692.0) (ISNI:0000 0004 0610 0264) 
 CHU, Laboratory of Cancer Biology, GIGA Cancer, University of Liege, Liege, Belgium (GRID:grid.4861.b) (ISNI:0000 0001 0805 7253) 
 Technische Universität Berlin, Institute of Biotechnology, Berlin, Germany (GRID:grid.6734.6) (ISNI:0000 0001 2292 8254) 
 Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC) / INSERM UMR-S 1258 / CNRS UMR7104/ Université de Strasbourg, Illkirch, France (GRID:grid.420255.4) (ISNI:0000 0004 0638 2716) 
 CNRS UPR9002, Institut Biologie Moléculaire et Cellulaire (IBMC), Strasbourg, France (GRID:grid.465534.5) (ISNI:0000 0004 0638 0833) 
 The Institute of Cancer Research, Division of Cancer Biology, London, UK (GRID:grid.18886.3f) (ISNI:0000 0001 1499 0189) 
 CHU, Laboratory of Cancer Biology, GIGA Cancer, University of Liege, Liege, Belgium (GRID:grid.4861.b) (ISNI:0000 0001 0805 7253); WEL Research Institute, WELBIO department, Wavre, Belgium (GRID:grid.509491.0) 
Pages
7692
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3100357070
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.